NVS

#43
Novartis AG
150.1 7 USD
-0.88%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
150.13
150.94
Faixa anual
112.38
170.46
Mudança diária
-0.88%
Mudança mensal
+2.50%
Mudança em 6 meses
+14.62%
Mudança anual
+30.58%
Fechamento anterior
151.5 0
Open
150.7 3
Mínimo
150.1 3
High
150.9 4
Volume
1 046
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
  • Market Capitalization 286.55 B
  • Employee 75 K
  • Founded 1996
  • CEO Vasant Narasimhan
  • Website www.novartis.com
  • Headquarter Switzerland
  • FIGI BBG000LYF3S8
  • Industry Fabricantes de medicamentos - gerais
Receita total
Lucro líquido
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa

Novartis AG

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz.

Notícias